Las Vegas, NV -- (SBWIRE) -- 10/29/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Fifth Street Finance Corp. (NASDAQ:FSC), Furmanite Corporation (NYSE:FRM), Clovis Oncology Inc (NASDAQ:CLVS), BioScrip Inc (NASDAQ:BIOS)
Fifth Street Finance Corp. (NASDAQ:FSC) managed to keep its fall at -0.34% on below -normal volume of 1.44 M shares. The stock settled at $2.05 after floating in a range of $10.22 to $10.32. Its latest price has reached market capitalization of $1.24 billion. Its 52-week range has been $9.66 to $11.13. Fifth Street Finance Corp. is a specialty finance company that lends to and invests in small and mid-sized companies in connection with investments by private equity sponsors.
Has FSC Found The Bottom and Ready To Move Up? Find Out Here
Furmanite Corporation (NYSE:FRM) traded up on a volume of 1.42 million, higher than its standard daily volume. Shares have gained 4.34% to $11.30. Over the last twelve months, the stock has gained 128.74% and faced a worst price of $3.69. Furmanite Corporation (Furmanite), along with its subsidiaries, provides specialized technical services, including on-line services, such as leak sealing, hot tapping, line stopping, line isolation, composite repair and valve testing.
For How Long FRM’s Gloss will Attract Investors? Find out via this report
Clovis Oncology Inc (NASDAQ:CLVS) settled -3.64% lower at $54.86 on above-normal volume of 1.37M shares during the last trading day. The stock has its 12-month high at $86.29 and 52-week low price was $11.19. It traded in a range of $54.20 to $64 during the last trading day. Clovis Oncology, Inc. is a United States-based biopharmaceutical company. The Company develops anti-cancer agents.
Will CLVS Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, BioScrip Inc (NASDAQ:BIOS) was down on low volume, trading at a volume of 139M versus its average daily volume of 1.83 million shares. At $7.43, the stock has attained market capitalization of 503.26 million. BioScrip, Inc. (BioScrip) is a provider of pharmacy and home health services, which partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and the delivery of prescription medications and home health services.
hy Should Investors Buy BIOS After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)